Eventide Healthcare & Life Sciences Fund Class A Shares (ETAHX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
29.94
+0.01 (0.03%)
Apr 25, 2025, 4:43 PM EDT
-9.33% (1Y)
| Fund Assets | 1.12B |
| Expense Ratio | 1.57% |
| Min. Investment | $1,000 |
| Turnover | n/a |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Dividend Growth | n/a |
| Payout Frequency | n/a |
| Ex-Dividend Date | n/a |
| Previous Close | 29.93 |
| YTD Return | -7.02% |
| 1-Year Return | -9.33% |
| 5-Year Return | -6.37% |
| 52-Week Low | 26.02 |
| 52-Week High | 36.83 |
| Beta (5Y) | 0.74 |
| Holdings | 86 |
| Inception Date | Dec 27, 2012 |
About ETAHX
Under normal market conditions, the fund invests at least 80% of its net assets (plus borrowings for investment purposes) in equity and equity-related securities of companies in the healthcare and life sciences sectors, including common stock, options, preferred stock and convertible debt. It may invest without limitation in securities of companies domiciled outside the United States either directly or through American Depositary Receipts ("ADRs"). The fund may invest in securities of companies of any market capitalization.
Category Health
Performance Rating Below Average
Risk Rating High
Stock Exchange NASDAQ
Ticker Symbol ETAHX
Share Class Class A Shares
Index S&P Biotechnology Select Industry TR
Performance
ETAHX had a total return of -9.33% in the past year, including dividends. Since the fund's inception, the average annual return has been 11.38%.
Top 10 Holdings
33.84% of assets| Name | Symbol | Weight |
|---|---|---|
| Verona Pharma plc | VRNA | 4.41% |
| Scholar Rock Holding Corporation | SRRK | 3.97% |
| Mirum Pharmaceuticals, Inc. | MIRM | 3.73% |
| US BANK MMDA - USBGFS 9 | n/a | 3.68% |
| Insmed Incorporated | INSM | 3.60% |
| Guardant Health, Inc. | GH | 3.43% |
| Blueprint Medicines Corporation | BPMC | 2.93% |
| Collegium Pharmaceutical, Inc. | COLL | 2.85% |
| Celldex Therapeutics, Inc. | CLDX | 2.65% |
| Aura Biosciences, Inc. | AURA | 2.59% |